The Statistical Consensus of Non-Inferiority Clinical Trail for NDA in CHINA XIA J.L., PhD. Prof of Biostatistics of FMMU On behalf of CCTS Working Group.
IRESSA Dr Rose McCormack Personalised Healthcare AstraZeneca A Presentation for the Translational Genomics Meeting Royal College of Physicians, London.
Non-Inferiority Margins in Clinical Trials. Difficult but necessary, or just a waste of time? Dr Simon Day Roche Products Ltd [email protected].
A Report from ECCO 14 Oral Chemotherapy in Colorectal Cancer John L. Marshall, MD Chief, Division of Hematology/Oncology Associate Director of Clinical.
Molycorp (MCP)
Patient Blood Management
